Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

JoAnn Vormschlag

Veristat Acknowledged for its Rapid Growth on the Inc. 5000 List of America’s Fastest-Growing Private Companies

Veristat Continues To Be Recognized for Its Positive Impact & Company Growth

Today we announced that we have been recognized once again by Inc. Magazine as one of America’s fastest-growing private companies. Veristat debuted on the list in 2015.  

What Are the Major/Common Types of Adaptive Designs Used in Clinical Trials Today?

An adaptive design is a clinical trial design that allows adaptations or modifications to aspects...

Biostatisticians: 3 Tips to Knowing When Adaptive Design Is Right for Your Clinical Trial

If you're reading this as a biostatistician or clinical trial professional, you know that the...

What You Missed at the Event of the Year | #DIA2016

Veristat joined over 6500+ life sciences professionals at the Drug Information Associations (DIA)...

Fueled by Growth, Veristat Continues Geographic Expansion

Veristat announced today that it is continuing its accelerated growth and geographic expansion with...

Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise

Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise

Appoints Mark Chang...

Veristat to Share Its Partnership Insights at GoBalto Webinar

The Role of Transparency in CRO-Sponsor Partnerships: Enabling Better Collaboration Models

Learn 'How to Manage Your Outsourcing Strategies' From Veristat CEO Patrick Flanagan At the Chief Medical Officer East Summit

Join Veristat, as well as Chief Medical Officers and R&D Executives from small to mid-sized life...

Veristat Expands Its Clinical Operations into Europe

Veristat Expands Its Clinical Operations into Europe